medline.ch Gastroenterologie Leber Leberzirrhose

	Enhanced Liver Fibrosis Test, FIB-4 and FibroScan: Real-World Prognostic Accuracy for MASLD in a Biopsy-Controlled Cohort. Liver Int Liguori A, D'Ambrosio F, Angelini G, Cefalo C, Galletti S, Cardinali S, Giustiniani MC, Marrone G, Biolato M, Rapaccini G, Pompili M, Grieco A, Mazza T, Urbani A, Sanguinetti M, Gasbarrini A, FPG, Miele L. PMID: 42394207 [PubMed - indexed for MEDLINE]
	Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics. BMJ Open Gastroenterol Li F, Li H, Juramt D, Kou K, Tacke F, Chen L. PMID: 42392673 [PubMed - indexed for MEDLINE]
	Cirrhosis outcomes on rurality and weekend admissions revisited: A contemporary analysis of the national inpatient sample. PLoS One Khalyfa A, Tu BH, Shi Q, Tanaka T. PMID: 42391252 [PubMed - indexed for MEDLINE]
	Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis. JAMA Oncol Oussalah A, Silva Rodriguez M, Conroy G, Bensenane M, Rousseau H, Ayav A, Guéant JL, Camara H, Baumann C, Laurent V, Bronowicki JP, SEPT9_CROSS Study Group. PMID: 42390849 [PubMed - as supplied by publisher]
	Comment on: Continuous versus intermittent anticoagulation during endoscopic treatment of esophageal varices in cirrhosis: a randomized controlled trial. Ther Adv Gastroenterol Fernandes J, Sharma S, Gupta R. PMID: 42389211 [PubMed]
	CD11c(+) T-Bet(+) B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases. Liver Int D'Orso S, La Gualana F, Vignone A, Acati S, Oliva F, Villa A, Maiorca F, Casato M, Stefanini L, Piconese S, Teocchi M, Borsellino G, Basili S, Alvaro D, Visentini M, Cardinale V. PMID: 42385197 [PubMed - indexed for MEDLINE]
	Machine learning phenotypes and heterogeneous albumin effects in cirrhotic AKI: a causal inference study. Intern Emerg Med Yu Z, Qin F. PMID: 42384297 [PubMed - as supplied by publisher]
	Impact of Cirrhosis Outcome Risk Estimator Score on Outcomes Following Pancreatectomy for Resectable Pancreatic Ductal Adenocarcinoma. In Vivo Yasui K, Takagi K, Fuji T, Nishiyama T, Okada N, Fujiwara T. PMID: 42379784 [PubMed - indexed for MEDLINE]
	Burden and Distribution of Multidrug-Resistant Bacteria Among Hospitalized Patients with Cirrhosis: A Systematic Review and Meta-Analysis. Clin Res Hepatol Gastroenterol Süffert LC, Pergher EAB, de Abreu HS, Abreu ES, Beis LPP, Padilha IH, Moraes BF, Passos PRC, Visentini LM, Friedrich F, Falci DR, Cerbino B, Onofrio FQ, Sterling RK, Cançado GGL. PMID: 42379292 [PubMed - as supplied by publisher]
	Prevalence of non-HLA antibodies and their association with FIB-4 index-based fibrosis risk in pediatric liver transplant recipients with long-term graft survival (>10 years). Front Immunol Cuesta-Martín de la Cámara R, Rodrigo-Castro A, Nozal P, Cámara C, Losantos-García I, Frauca-Remacha E, Hierro-Llanillo L, Muñoz-Bartolo G, Lledín-Barbacho MD, Mancebo E, Castro-Panete MJ, Paz-Artal E, López-Granados E, Sánchez-Zapardiel E. PMID: 42375352 [PubMed - indexed for MEDLINE]
	Clinical Characteristics, Risk Factors, and Outcomes of Portal Vein Thrombosis in Non-cirrhotic Patients: A Retrospective Study. Cureus Al-Hagawi Y, Alqahtani NI, Alsharif SN, Chakik RM, Laeeq SM, Elgazzar MH, Alqahtani SS, Alhajjaj MN, Al-Mani SY Sr, Asiri BM, Alqahtani MA, Alqahtani AA, Ayied HA, Alahmari AF. PMID: 42371451 [PubMed]
	Implications of Liver Failure Cutoffs for Mortality Prediction in Hospitalized Cirrhosis Patients: A Multicentric Study. Gastro Hep Adv Valsan A, Kumar K, Roy A, Silvey S, Bajaj JS, Kulkarni AV, Liver Failure Investigators. PMID: 42367752 [PubMed]
	Direct Oral Anticoagulant Type and Dose in Atrial Fibrillation With Decompensated Cirrhosis: A Propensity-Matched Analysis. Gastro Hep Adv Zanco J, Vignarajah A, Arsanjani R, Carey EJ, Scott LR, Sorajja D. PMID: 42367751 [PubMed]
	The effect of TIPS on the development of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. BMC Gastroenterol Xu X, Jiang M, Fu Y, Meng Q. PMID: 42366368 [PubMed - as supplied by publisher]
	Novel and Emerging Biomarkers in the Diagnosis and Management of Kidney Disease in Cirrhosis. J Gastrointestin Liver Dis Reznik E, Reidy D, Ying X, Schonfeld E, Jesudian A. PMID: 42365654 [PubMed - indexed for MEDLINE]
	Sodium-Glucose Cotransporter-2 Inhibitors Are Associated with Improved Survival in Patients with Cirrhosis. J Gastrointestin Liver Dis Ahmed H, Gomaa S, Alazzeh M, Darwish M, Mansour MK, Lauchner J. PMID: 42365643 [PubMed - indexed for MEDLINE]
	Assessment of hepatic fibrosis in Egyptian children and adolescents with beta thalassemia major: a single center study. Eur J Pediatr Elhady MA, Kaddah M, Marzouk A, Mogahed EA, Yassin NA. PMID: 42362985 [PubMed - indexed for MEDLINE]
	Association between Red Cell Distribution Width (RDW)-related inflammatory biomarkers and prognosis in ICU Cirrhosis patients: Evidence from the MIMIC-IV. PLoS One Zhu X, Lin C, Liu X, Huang Z, Li Y. PMID: 42361018 [PubMed - indexed for MEDLINE]
	Inflammatory activity stratification improves liver stiffness diagnosis of fibrosis in autoimmune hepatitis. Front Immunol Huang Y, Liu D, Li Y, Zhang X, Tang Y. PMID: 42358983 [PubMed - indexed for MEDLINE]
	SGLT-2 Inhibitors for Ascites Management in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Available Evidence. Int J Hepatol Al Ghnaimat A, Ahmed NAT, Al-Azzawi OM, Ibrahim EA, Rayyan R, Alkloub S, Al Joufi E, Breish EE, Shaik S, Al-Kadhimi N, Al Masalha B, Abdelbaqi H, Abouda DA. PMID: 42358872 [PubMed]

Artikel 1 - 20 / 38848

Seite 1 von 1943

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung